Application 219660

Type
NDA
Sponsor
APOTEX

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
002RuxolitinibRuxolitinibTABLET; ORAL10MGNoNo
003RuxolitinibRuxolitinibTABLET; ORAL15MGNoNo
004RuxolitinibRuxolitinibTABLET; ORAL2MGNoNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
84285ORIG 2025-11-24